Skip to main content
  • Register
  • My watchlists
  • Help
  • Contact us
  • Log out of your HL account

EKF Diagnostics Holdings plc (EKF) Ordinary 1p

Sell:32.60p Buy:34.00p 0 Change: 0.05p (0.15%)
Market closed |  Prices as at close on 22 October 2019 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:32.60p
Buy:34.00p
Change: 0.05p (0.15%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 22 October 2019 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:32.60p
Buy:34.00p
Change: 0.05p (0.15%)
Market closed |  Prices as at close on 22 October 2019 Prices delayed by at least 15 minutes | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

EKF Diagnostics Holdings plc is engaged in developing, manufacturing and supplying of products and services into the in-vitro diagnostic (IVD) market place. The Company manufactures and sells diagnostic instruments, reagents and certain ancillary products. The Company's point-of-care range includes hemoglobin analyzers, HbA1c analyzers and glucose analyzers for use in the screening, monitoring and diagnosis of patients, as well as rapid tests for pregnancy and common infectious diseases. The Company's Central Laboratory division includes a range of products for use in both large and small laboratory facilities. Its subsidiary, EKF Life Sciences, provides bulk diagnostic enzyme manufacturing and fermentation services. EKF Life Sciences specializes in producing enzymes, including Salicylate Hydroxylase and Beta-Hydroxybutyrate Dehydrogenase. Its products include Quo-Test A1c, Biosen C-Line and Biosen S-Line, STAT-Site M B-HB analyzer, sTNFR1 biomarker test kits and Altair 240.

Contact details

Address:
Avon HSE, 19 Stanwell Road
PENARTH
CF64 2EZ
United Kingdom
Telephone:
+44 (029) 20710570
Website:
https://www.ekfdiagnostics.com/

Important dates

Future events
There are no future events available.
Past events
Interim results 10 September 2019 10/09/19
Trading Announcement 15 July 2019 15/07/19
AGM 02 May 2019 02/05/19
Final results 13 March 2019 13/03/19
Trading Announcement 16 January 2019 16/01/19

General stock information

EPIC:
EKF
ISIN:
GB0031509804
Market cap:
£150.99 million
Shares in issue:
454.09 million
Sector:
Health Care Equipment & Services
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel

  • Julian Baines
    Chief Executive Officer, Executive Director
  • Richard Evans
    Finance Director, Chief Operating Officer, Executive Director

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account
Deal now

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.